Topic

Chief Design Officer and Co-founder, uMotif

Articles

Evolving mindsets are opening the door for industry to utilize new mediums for understanding patients.

Engaging Patients With Behavioral Science and Patient-centered Technology

Research has suggested that cough may be associated with worse outcomes in pulmonary fibrosis. Boehringer Ingelheim will assess how monitoring cough and crackles with the RESP Biosensor can be used to monitor the status of patients with this disease.

Strados Labs Remote Wearable in BI IPF Trial

Digitalization has been progressively facilitating increased access to trials by helping alleviate logistical burdens, but not much is known about how these tools can address the needs of patients with multiple chronic conditions.

Digitalization Trends in Tackling the Complexity of Clinical Trials for Patients with Multiple Health Conditions

Moving beyond the pill to extend the value being delivered to patients.

Changing the Digital Health Playing Field: A New Era

The role of the cloud in realizing the practical benefits of mHealth in clinical trials.   

The Future of Mobility and Medicine

In this interview, Dr. David Lee Scher adds his perspective on how digital health is changing in both healthcare and clinical trial settings.

Digital Health Lacks Data Dimensionality for Clinical Trials

The Duke Margolis Center for Health Policy (DMCHP) recently collaborated with the FDA to release an mHealth action plan entitled "Mobilizing mHealth Innovation for Real-World Evidence Generation."

New mHealth Action Plan Released

Austin Speier, VP of Emerging Technologies at Precision for Medicine, recently spoke about mHealth regulatory pathways at PanAgora’s Mobile Innovations Summit, and will elaborate further in this Q&A interview.  

FDA and Industry Move on mHealth Guidance

Jeff Lee had the opportunity to be a moderator at the Mobile in Clinical Trials event where he sat down with mobile experts within the pharmaceutical industry. The session allowed for new observations in regards to the value that these mobile technologies have within clinical trials.

Pharma Roundtable: Breaking Barriers to Using Mobile Technology on Clinical Trials

As the clinical trials industry starts to incorporate mHealth initiatives into their trials, study teams now have to determine the extent of their ICF consent forms during study deployment, and how to cover mHealth activities within these forms.